Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1.
Abend JR, Sathe A, Wrobel MB, Knapp M, Xu L, Zhao L, Kim P, Desai S, Nguyen A, Leber XC, Hein A, Scharenberg M, Shaul J, Ornelas E, Wong K, Pietzonka T, Sterling LM, Hodges MR, Pertel P, Traggiai E, Patick AK, Kovacs SJ.
Abend JR, et al. Among authors: kovacs sj.
Am J Transplant. 2024 Nov;24(11):1994-2006. doi: 10.1016/j.ajt.2024.07.002. Epub 2024 Jul 10.
Am J Transplant. 2024.
PMID: 38996969
Free article.
Clinical Trial.